Event announcement: Artemesinin Resistance - threats and responses

WWARN Published Date

We are pleased to invite you to join a group of experts from the WWARN Network, the University of Oxford, the London School of Hygiene & Tropical Medicine and the Malaria and ACT Consortia for an event on the eve of World Malaria Day 2014.
 
We hope to see you in London on 24th April. Should you have any further questions, please don't hesitate to email: info@wwarn.org

Artemesinin Resistance - threats and responses

Thursday, April 24th at 5.00pm

John Snow Lecture Theatre 
London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT
Directions to the London School
 
 

One of the mainstays of recent successes in malaria control has been the effective deployment of artemisinin-based combination therapy (ACT) in malaria endemic countries worldwide. As with antimalarial treatments used in the past, ACT are under threat from the development of resistance by the malaria parasite Plasmodium falciparum. To mark World Malaria Day 2014 we are convening a group of experts to discuss both the threat posed by parasite drug resistance and responses to counteract this threat.

Introduction - ACT efficacy world-wide 
Dr. Colin Sutherland (Malaria Reference Laboratory) 

Epidemiology of resistance in Asia & Africa
Dr. Christian Nsanzabana (Worldwide Antimalarial Resistance Network)

Transmission-blocking strategies for malaria - can we stop the spread of artemisinin resistance?
Prof. Chris Drakeley (Malaria Centre)

Tracking the spread of artemisinin-resistant malaria
Prof. Nick White (Mahidol-Oxford Research Unit, Bangkok)

Invest in the Future: Defeat Malaria
Dr. Sylvia Meek (Malaria Consortium)

Panel Discussion 
Chaired by Prof. David Schellenberg (ACT Consortium)

To register for this event hosted by the London School of Hygiene & Tropical Medicine, please visit:
https://www.eventbrite.co.uk/e/artemisinin-resistance-threats-and-responses-registration-11173342769

Image removed.        Image removed.     Image removed.